In diabetic encephalopathy, the elevated levels of MG during hyperglycemia and the downregulation of Glo-1 induced by oxidative stress lead to a clear increase in advanced glycation end-products (AGEs) (Liu et al., 2013a; Zhu et al., 2018). The gene discussed is GLO1; the disease is diabetic encephalopathy.